Bennion Callister Janis, Pickering-Brown Stuart M
Institute of Brain, Behaviour and Mental Health, University of Manchester, Oxford Road, Manchester, M13 9PT, UK.
Institute of Brain, Behaviour and Mental Health, University of Manchester, Oxford Road, Manchester, M13 9PT, UK.
Exp Neurol. 2014 Dec;262 Pt B:84-90. doi: 10.1016/j.expneurol.2014.06.001. Epub 2014 Jun 8.
One of the most interesting findings in the field of neurodegeneration in recent years is tfche discovery of a genetic mutation in the C9orf72 gene, the most common mutation found to be causative of sporadic and familial frontotemporal lobar degeneration (FTLD), amyotrophic lateral sclerosis (ALS) and concomitant FTD-ALS (DeJesus-Hernandez et al., 2011b; Renton et al., 2011). While clinical and molecular data, such as the identification of TDP-43 being a common pathological protein (Neumann et al., 2006) have hinted at such a link for years, the identification of what was formally known as "the chromosome 9 FTLD-ALS gene" has provided a foundation for better understanding of the relationship between the two. Indeed, it is now recognized that ALS and FTLD-TDP represent a disease spectrum. In this review, we will discuss the current genetic and pathological features of the FTLD-ALS spectrum.
近年来神经退行性变领域最有趣的发现之一是在C9orf72基因中发现了一种基因突变,这是在散发性和家族性额颞叶痴呆(FTLD)、肌萎缩侧索硬化症(ALS)以及合并性FTD-ALS中发现的最常见的致病突变(德赫苏斯-埃尔南德斯等人,2011年b;伦顿等人,2011年)。虽然多年来临床和分子数据,如鉴定出TDP-43是一种常见的病理蛋白(诺伊曼等人,2006年)已暗示了这样一种联系,但对曾被正式称为“9号染色体FTLD-ALS基因”的鉴定为更好地理解两者之间的关系奠定了基础。事实上,现在人们认识到ALS和FTLD-TDP代表一种疾病谱。在本综述中,我们将讨论FTLD-ALS谱的当前遗传和病理特征。